Top Five Articles on GenomeWeb Last Week: Illumina, COVID-19, Merck, and More

NEW YORK – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:

1. Illumina Obtains Preliminary Injunction Against BGI 
2. Illumina Acquires Informatics Firm BlueBee 
3. Blood Group Locus Contributes to COVID-19 Severity Risk, GWAS Finds 
4. FDA Approves Merck's Keytruda, Foundation Medicine CDx for TMB-High Solid Tumors 
5. Natera Sues Progenity, Alleging Noninvasive Prenatal Test Infringes Patents